US 10493151
Etanercept formulations stabilized with sodium chloride
granted A61KA61K38/1793A61K39/39591
Quick answer
US patent 10493151 (Etanercept formulations stabilized with sodium chloride) held by Coherus BioSciences, Inc. expires Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Coherus BioSciences, Inc.
- Grant date
- Tue Dec 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K38/1793, A61K39/39591